Quick answer
Why is NAD+ at the center of aging research, and how strong is the evidence? NAD+ is central because it is both a redox cofactor for mitochondrial metabolism and a consumed substrate for sirtuins, PARPs and CD38, so changes in its supply plausibly connect metabolism, DNA repair and gene regulation. Published studies report lower NAD levels in aged mice and worms, rising CD38 activity with age in mice, and age-dependent NAD measurements in human tissue, but the human data are cross-sectional and method-dependent, and the findings are association and model-organism results, not demonstrations of outcome in people. This article summarizes what each study type can and cannot show. NAD+ is supplied for laboratory research use only.
NAD+ is often described as "the molecule at the center of longevity research". The description is half right. The molecule is central to a great deal of biochemistry, and that biochemistry is studied in aging models. What is not established by that centrality is any claim about what altering NAD+ would do in a living person, and this article makes no such claim. It organizes the literature by study type, from yeast and worm genetics through mouse biochemistry to measurements in human tissue, and notes the measurement problems that make cross-study comparison hard. The product context is on the NAD+ 1000 mg product page, which describes the compound for cellular-energy metabolism, mitochondrial-function and sirtuin-pathway research; for the broader library entry see the NAD+ research overview. All material is for laboratory research use only.
Why the molecule keeps appearing in aging papers
Three roles explain the attention. NAD+ carries electrons between metabolic reactions and the respiratory chain. It is a co-substrate for sirtuins, whose founding member Sir2 was shown to be an NAD-dependent histone deacetylase (Imai et al., 2000). And it is consumed by DNA-repair and signaling enzymes. Reviews of the field, including Verdin (2015) and Covarrubias and colleagues (2021), lay out how these roles connect energy metabolism, chromatin and stress responses to aging biology, and Cantó and colleagues (2015) discuss the balance between mitochondrial and nuclear NAD+ use. The chemistry itself is covered in the sibling article on NAD+ structure and biochemical roles; the enzyme-level assays are in the sibling article on sirtuin reaction chemistry.
Study type 1: genetic and model-organism work
Work in simple organisms provides the most direct tests of mechanism. One study reported that NAD+ levels are reduced in aged mice and in Caenorhabditis elegans, that decreasing NAD+ further shortened worm lifespan, and that genetic or pharmacological restoration of NAD+ was reported to prevent age-associated metabolic decline and to promote longevity in worms, with effects dependent on the sirtuin sir-2.1 and involving the mitochondrial unfolded protein response and the transcription factor DAF-16 (Mouchiroud et al., 2013). That is a mechanistic result in a short-lived invertebrate, and the authors' framing is of a pathway, not of a result transferable across species.
The mouse is the next step. A study of CD38 reported that expression and activity of this NADase increase with aging in mice and that CD38 was required for the age-related NAD decline and mitochondrial dysfunction observed, through a pathway involving regulation of SIRT3 activity (Camacho-Pereira et al., 2016). This is one of several lines of evidence that age-related change in NAD levels is regulated by consumption, not only by synthesis.
Study type 2: measurements in human tissue
Human data are cross-sectional measurements, not interventions. One group measured age-associated changes in oxidative stress and NAD+ metabolism in human pelvic skin samples obtained from donors ranging from newborns to age 77 (Massudi et al., 2012). Another used a magnetic-resonance method to assess NAD+ and NADH contents and the NAD+/NADH redox ratio noninvasively in the brains of healthy volunteers and reported age dependence (Zhu et al., 2015). These are associations between age and a measured quantity in a tissue at one time. They do not isolate cause, and each concerns one tissue: skin and brain are not interchangeable with muscle, liver or blood.
| Study type | Example | What it can show | What it cannot show |
|---|---|---|---|
| Invertebrate genetics | NAD+/sirtuin pathway and lifespan in worms (Mouchiroud et al., 2013) | A mechanism that depends on a specific gene | That the pathway limits lifespan in mammals |
| Mouse biochemistry | CD38 and age-related NAD decline (Camacho-Pereira et al., 2016) | A regulator of NAD levels in one species and strain | Relevance of the same regulator to other species |
| Human tissue cross-section | Skin samples across ages (Massudi et al., 2012) | That a measured value differs with age in one tissue | Cause, or generality to other tissues |
| Human in vivo imaging | MR-based NAD assay in brain (Zhu et al., 2015) | Feasibility of noninvasive measurement; age dependence | Cellular compartments or flux |
Why NAD measurements are hard to compare
Quoted "NAD levels" depend on how the sample was taken and analyzed. NAD+ and NADH interconvert and degrade during extraction, so extraction chemistry is a source of variance. UV-based HPLC offers accuracy for NAD+ in tissue when carefully done (Yoshino and Imai, 2013), but targeted LC-MS was developed because UV detection lacks the specificity needed for complex mixtures of NAD+ metabolites (Trammell and Brenner, 2013). Free versus protein-bound pools, mitochondrial versus nuclear compartments, and tissue handling before freezing are additional variables.
| Method | Reads | Limit |
|---|---|---|
| Reverse-phase HPLC, UV | NAD+ in extracts (Yoshino and Imai, 2013) | Specificity in complex samples |
| Targeted LC-MS | NAD+ and related metabolites (Trammell and Brenner, 2013) | Needs internal standards and instrument time |
| Magnetic-resonance assay | NAD+, NADH and redox ratio in living brain (Zhu et al., 2015) | Whole-region signal; high-field scanner required |
A reader comparing two papers should check whether the units, the extraction and the detection method match before comparing the numbers.
The same applies to a laboratory preparing its own standards. The accuracy of a calibration curve depends on the concentration of the stock, which depends on the molar mass and the net content of the material; see NAD+ purity testing and how to read a COA.
Reading headlines about 'declining NAD'
The statement "NAD+ declines with age" is a summary of several different findings, and its strength differs by tissue and species. In worms and mice the decline has been reported in the studies above. In humans the evidence consists of tissue cross-sections of limited size and a single imaging study. The statement that the decline is the cause of age-related decline in function is a hypothesis, tested in model organisms, not a conclusion from the human data. A reader should also keep apart three different claims: that a level changes with age, that the change is driven by a particular enzyme, and that changing it alters an outcome. Only the first two are the subject of the work summarized here.
Designing a cell or animal study around NAD+
For laboratory work, a few design points follow from the literature.
- Measure NAD+ and NAD+ consumers together. If CD38 or PARP activity changes with the condition, NAD+ supply alone will not tell the story.
- Define the compartment. State whether whole-cell, mitochondrial or nuclear NAD is meant, and whether the method can resolve it.
- Control the extraction. Use the same quench and extraction for all groups and include a spiked-recovery check.
- Control for the sex, age and strain of the animals. Sex and age as study variables are discussed in the sibling article on study design.
- Report the readout, not the narrative. A change in NAD+ is a measurement; a change in lifespan or function is a separate measurement.
Complementary reading on mitochondria-focused models is in the MOTS-c research overview, and on the combined NAD+ and MOTS-c listing in NAD+ and MOTS-c blend explained. Where a study needs the material itself, the shop lists the catalog and the calculator handles stock arithmetic.
Limits of this article
This summary relies on abstracts and titles of the cited studies and on review articles; it does not reanalyze data. It does not evaluate precursors such as nicotinamide mononucleotide beyond noting that they are different compounds, and it makes no statement on any use in people. Readers who want the original numbers should consult the cited papers directly.
Frequently asked questions
Does NAD+ decline with age?
Published studies report lower NAD levels in aged mice and worms, and age-dependent measurements in human skin and brain. The human data are cross-sectional and tissue-specific, so the statement needs the qualifier of species, tissue and method.
What is CD38 and why is it relevant?
CD38 is an NADase, an enzyme that breaks down NAD+. One mouse study reported that its expression and activity rise with age and that it was required for the age-related NAD decline observed.
Is low NAD+ shown to cause aging?
No. In worms, pathway experiments link NAD+ and sirtuin activity to lifespan. For mammals, and especially humans, the evidence is associative or from model organisms.
How is NAD+ measured in human tissue?
By HPLC with UV detection, by targeted LC-MS, and in the brain by a magnetic-resonance method. Results are not directly interchangeable between methods.
Why do papers report different NAD+ values?
Extraction chemistry, interconversion of NAD+ and NADH, compartment, tissue handling and detection method all change the number. Compare methods before comparing values.
What role do sirtuins play?
They are NAD+-dependent deacylases; Sir2, the founding member, was shown to be an NAD-dependent histone deacetylase.
Are the worm results applicable to humans?
They show a mechanism in an invertebrate. Transfer to mammals has to be tested separately and is not shown by the worm work.
Is this article making a claim about taking NAD+ or its precursors?
No. It summarizes laboratory and tissue-measurement literature. The material is sold for laboratory research use only.
What should an animal study control?
Age, sex and strain, the tissue and compartment measured, extraction method, and the activity of NAD-consuming enzymes alongside NAD+.
Where can I read more on NAD+ chemistry?
The NAD+ research overview, and the sibling articles on NAD+ structure and biochemical roles, sirtuin assay design and solution stability.
Research-use statement
All material discussed here is supplied for laboratory research use only; not for human consumption, and not a drug, food or cosmetic.
Related reading: NAD+ Biosynthesis: Precursor Routes and Assay Design, NAD+ and Mitochondria: Respirometry and Mitonuclear Readouts, NAD+ in Axon Degeneration and Neurodegeneration Models.
References
- Verdin E. NAD + in aging, metabolism, and neurodegeneration. Science. 2015;350(6265):1208-1213. doi:10.1126/science.aac4854
- Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2020;22(2):119-141. doi:10.1038/s41580-020-00313-x
- Cantó C, Menzies KJ, Auwerx J. NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus. Cell Metabolism. 2015;22(1):31-53. doi:10.1016/j.cmet.2015.05.023
- Imai Si, Armstrong CM, Kaeberlein M, Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 2000;403(6771):795-800. doi:10.1038/35001622
- Mouchiroud L, Houtkooper RH, Moullan N, Katsyuba E, Ryu D, Cantó C, et al. The NAD+/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling. Cell. 2013;154(2):430-441. doi:10.1016/j.cell.2013.06.016
- Camacho-Pereira J, Tarragó MG, Chini CC, Nin V, Escande C, Warner GM, et al. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metabolism. 2016;23(6):1127-1139. doi:10.1016/j.cmet.2016.05.006
- Massudi H, Grant R, Braidy N, Guest J, Farnsworth B, Guillemin GJ. Age-Associated Changes In Oxidative Stress and NAD+ Metabolism In Human Tissue. PLoS ONE. 2012;7(7):e42357. doi:10.1371/journal.pone.0042357
- Zhu XH, Lu M, Lee BY, Ugurbil K, Chen W. In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences. Proc. Natl. Acad. Sci. U.S.A.. 2015;112(9):2876-2881. doi:10.1073/pnas.1417921112
- Yoshino J, Imai Si. Accurate Measurement of Nicotinamide Adenine Dinucleotide (NAD+) with High-Performance Liquid Chromatography. Methods in Molecular Biology. 2013;:203-215. doi:10.1007/978-1-62703-637-5_14
- Trammell SA, Brenner C. TARGETED, LCMS-BASED METABOLOMICS FOR QUANTITATIVE MEASUREMENT OF NAD + METABOLITES. Comput Struct Biotechnol J. 2013;4(5):e201301012. doi:10.5936/csbj.201301012
